Search - tctmd.com

Displaying 101 - 120 of 1179

Sort: Relevancy | Date

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Caitlin E. Cox

March 30, 2025

News Conference News ACC 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Michael O'Riordan

March 30, 2025

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Michael O'Riordan

March 29, 2025

News Daily News ACC 2025

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

L.A. McKeown

March 29, 2025

News Conference News ACC 2025

WARRIOR: No Clear Answers on How to Best Treat INOCA

Yael L. Maxwell

March 29, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Daily News

Embolic Protection Use During TAVI Declined After PROTECTED TAVR

Todd Neale

March 21, 2025

News Conference News

NOW PUBLISHED: Compared with PV Isolation Alone, AI-Guided Ablation Lowers AF at 12 Months

Yael L. Maxwell

February 18, 2025

Presentation THT 2025

Win Ratio Analysis of Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: REBALANCE-HF Randomized Trial

Presenter: Marat Fudim

February 12, 2025

Presentation THT 2025

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Presenter: Nir Uriel

February 12, 2025

Presentation THT 2025

Sodium Glucose CoTransporter-2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial

Presenter: Mary Acosta

February 12, 2025

Presentation THT 2025

Transcatheter Pulmonary Artery Banding [PAB] for HFrEF: Two Year Follow Up and Invasive Exercise Hemodynamics From the Ongoing First-In-Human Trial

Presenter: Sean Pinney

February 12, 2025

Presentation THT 2025

Burst Steroid Therapy and Quality of Life in Patients With Acute Heart Failure: Insights From the CORTAHF Trial

Presenter: Matteo Pagnesi

February 12, 2025

Presentation THT 2025

A Digital Platform to Optimize Guideline Directed Heart Failure Therapy: Primary Results of the AIM-POWER Randomized Controlled Trial

Presenter: Akshay Desai

February 12, 2025

Presentation THT 2025

Special Late-Breaking Clinical Science Abstract: Effects of Anti-Inflammatory Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis

Presenter: Beth Davison

February 12, 2025

Presentation THT 2025

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Presenter: Barry Borlaug

February 11, 2025

Presentation THT 2025

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results

Presenter: Javed Butler

February 11, 2025

Presentation THT 2025

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) – The FASTR Trial

Presenter: James Udelson

February 11, 2025

Presentation THT 2025

Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial

Presenter: Gregg W. Stone

February 11, 2025

Presentation THT 2025

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Presenter: Sanjiv Shah

February 11, 2025

Advertisement

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients

WARRIOR: No Clear Answers on How to Best Treat INOCA

What’s Going to Be Hot at ACC 2025?

Embolic Protection Use During TAVI Declined After PROTECTED TAVR

NOW PUBLISHED: Compared with PV Isolation Alone, AI-Guided Ablation Lowers AF at 12 Months

Win Ratio Analysis of Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure With Preserved Ejection Fraction: REBALANCE-HF Randomized Trial

Impact of Age on Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial

Sodium Glucose CoTransporter-2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial

Transcatheter Pulmonary Artery Banding [PAB] for HFrEF: Two Year Follow Up and Invasive Exercise Hemodynamics From the Ongoing First-In-Human Trial

Burst Steroid Therapy and Quality of Life in Patients With Acute Heart Failure: Insights From the CORTAHF Trial

A Digital Platform to Optimize Guideline Directed Heart Failure Therapy: Primary Results of the AIM-POWER Randomized Controlled Trial

Special Late-Breaking Clinical Science Abstract: Effects of Anti-Inflammatory Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) – The FASTR Trial

Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content